United Therapeutics Chairperson, CEO Martine Rothblatt reports USD 4.99 million common stock disposal

Bitget2026/10/02 20:33

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

United Therapeutics Chairperson and CEO Martine A. Rothblatt reported an option exercise for 9,500 shares on Oct. 1, 2026.
Shares were acquired at USD 117.76, held indirectly by a trust; post-transaction holding in that trust was 333,943 shares.
The same trust sold 8,994 shares on Oct. 1, 2026 in multiple trades at prices from USD 560.05 to USD 584.6622.
Trust holdings fell to 324,443 shares following the sales.
Rothblatt also reported 40,513 shares held directly, with additional indirect holdings through family trusts.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000155), on October 02, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

United Therapeutics Chairperson, CEO Martine Rothblatt reports USD 4.99 million common stock disposal

You may also like

Crypto prices